| Considerations and challenges for sex-aware drug repurposing JL Fisher, EF Jones, VL Flanary, AS Williams, EJ Ramsey, BN Lasseigne Biology of sex Differences 13 (1), 1-23, 2022 | 17 | 2022 |
| Cell‐type‐specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1S858R Schinzel Giedion Syndrome mice JH Whitlock, TM Soelter, TC Howton, EJ Wilk, VH Oza, BN Lasseigne Journal of Cellular and Molecular Medicine 27 (22), 3565-3577, 2023 | 9 | 2023 |
| The landscape of SETBP1 gene expression and transcription factor activity across human tissues JH Whitlock, EJ Wilk, TC Howton, AD Clark, BN Lasseigne Plos one 19 (1), e0296328, 2024 | 8 | 2024 |
| Ten simple rules for using public biological data for your research VH Oza, JH Whitlock, EJ Wilk, A Uno-Antonison, B Wilk, M Gajapathy, ... PLoS computational biology 19 (1), e1010749, 2023 | 8 | 2023 |
| Computational advancements in cancer combination therapy prediction VL Flanary, JL Fisher, EJ Wilk, TC Howton, BN Lasseigne JCO Precision Oncology 7, e2300261, 2023 | 5 | 2023 |
| Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion EJ Wilk, TC Howton, JL Fisher, VH Oza, RT Brownlee, KC McPherson, ... Molecular Medicine 29 (1), 67, 2023 | 3 | 2023 |
| Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates JL Fisher, EJ Wilk, VH Oza, SE Gary, TC Howton, VL Flanary, AD Clark, ... FEBS Open bio 14 (5), 803-830, 2024 | 2 | 2024 |
| Evaluating cancer cell line and patient‐derived xenograft recapitulation of tumor and non‐diseased tissue gene expression profiles in silico AS Williams, EJ Wilk, JL Fisher, BN Lasseigne Cancer Reports 6 (9), e1874, 2023 | 2 | 2023 |
| Rosalution: Supporting data accessibility, integration, curation, interoperability, and reuse for precision animal modeling AE Uno-Antonison, R Fatima, J Scherer, A Moss, D Brown, A Foksinska, ... Journal of Open Source Software 8 (90), 5443, 2023 | 1 | 2023 |
| Evaluating Sex-Biased Adverse Event-Associated Drugs to Improve Kidney Disease Drug Prioritization: TH-PO116 BN Lasseigne, TC Howton, E Wilk Journal of the American Society of Nephrology 35 (10S), 10.1681, 2024 | | 2024 |
| Evaluation of altered cell-cell communication between glia and neurons in the hippocampus of 3xTg-AD mice at two time points TM Soelter, TC Howton, EJ Wilk, JH Whitlock, AD Clark, A Birnbaum, ... bioRxiv, 2024 | | 2024 |
| Streamlining Drug Repurposing: Optimizing Candidate Prioritization to Facilitate Clinical Adoption and Minimize Attrition Rates E Jones, S Taluri, E Wilk, B Lasseigne | | 2024 |
| PANDA cell-type-specific networks for S858R and WT mouse kidney JH WHitlock, TM Soelter, TC Howton, EJ Wilk, V Oza, B Lasseigne | | 2023 |
| CollecTRI Data for Investigation of SETBP1 gene expression and transcription factor activity across human tissues JH Whitlock, EJ Wilk, TC Howton, AD Clark, B Lasseigne | | 2023 |
| PANDA cell-type-specific networks for S858R and WT mouse cerebral cortex JH Whitlock, TM Soelter, TC Howton, EJ Wilk, V Oza, B Lasseigne | | 2023 |
| Data for investigation of cell-type-specific expression and regulation in Setbp1 (p. S858R) atypical SGS male mice JH Whitlock, TM Soelter, VH Oza, EJ Wilk, T Howton, B Lasseigne | | 2023 |
| Ten Simple Rules for Using Public Data for Your Research VH Oza, JH Whitlock, EJ Wilk, A Uno-Antonison, B Wilk, M Gajapathy, ... | | 2022 |
